# US 10,500,346 B2 · Assembly for a drug delivery device > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 10,500,346 B2 - Document ID: US10500346B2 - Status: Granted - Kind: B2 - Application number: 14/915,440 - Filed: 2014-09-03 - Published: 2016-12-22 - Granted: 2019-12-10 - Earliest claimed: 2013-09-03 - Assignees: Sanofi - Applicants: Sanofi - Inventors: Michael Bainton; David Aubrey Plumptre - Web page: https://patentgrep.com/patent/US10500346B2 ## CPC - A61M 5/31553: {without axial movement of dose setting member} - A61M 5/24: Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or cartridges, e.g. automatic - A61M 5/31585: {the component being manually operated or triggered by an axially moving actuator operated by user, e.g. an axially movable injection button} - A61M 2005/3126: {related to dosing} - A61M 2205/581: by audible feedback - A61M 2205/582: by tactile feedback - A61M 2205/584: having a color code - A61M 2205/586: Ergonomic details therefor, e.g. specific ergonomics for left or right-handed users - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} ## Abstract An assembly for a drug delivery device includes a dose setting member to be moved by a user from an initial position to a dose sett position and a housing part. The dose setting member and the housing part are connected to form a housing of the assembly. The assembly includes an activation member coupled to the dose setting member to convert a rotation of the dose setting member with respect to the housing into a proximal movement of the activation member with respect to the dose setting member when the dose setting member is moved from the initial position to the dose set position. The activation member has a proximal end section extending from an activation face of the activation member, where in the initial position of the dose setting member, the proximal end section is fully in or slightly protrudes from the proximal end of the housing. ## Claims ### Claim 1 An assembly for a drug delivery device, the assembly comprising: a dose setting member configured to be moved by a user from an initial position to a dose set position to set a dose, a main housing part, wherein the dose setting member and the main housing part are connected to form a housing of the assembly, the housing having a proximal end and a distal end, and an activation member which is coupled to the dose setting member to convert a rotation of the dose setting member with respect to the housing into a proximal movement of the activation member with respect to the dose setting member when the dose setting member is moved from the initial position to the dose set position, the activation member having a proximal end section extending from an activation face of the activation member, the activation face being configured for an interaction with the user, wherein the assembly is configured such that, in the initial position of the dose setting member, the proximal end section of the activation member is fully received in the housing or slightly protrudes by a protruding distance beyond the proximal end of the housing, wherein the activation member is coupled to a piston rod of the assembly such that the activation member is moved proximally with respect to the dose setting member when the dose setting member is moved from the initial position to the dose set position, and wherein the assembly is further configured such that, when the set dose is increased, an axial extension of the drug delivery device also increases in proportion as the activation member moves proximally with respect to the dose setting member. ### Claim 2 (depends on 1) The assembly according to claim 1, wherein the protruding distance is less than a length of the dose setting member. ### Claim 3 (depends on 1) The assembly according to claim 1, wherein the protruding distance is less than or equal to 20% of a maximum distance by which the activation member can be moved proximally with respect to the dose setting member during a dose setting operation. ### Claim 4 (depends on 1) The assembly according to claim 1, wherein the protruding distance is zero. ### Claim 5 (depends on 1) The assembly according to claim 1, wherein the dose setting member is axially secured to but rotatable with respect to the main housing part. ### Claim 6 (depends on 1) The assembly according to claim 1, wherein the dose setting member defines the proximal end of the housing. ### Claim 7 (depends on 1) The assembly according to claim 1, wherein, in the initial position of the dose setting member, the proximal end of the housing ends flush with the activation face of the activation member. ### Claim 8 (depends on 1) The assembly according to claim 1, wherein, during setting of the dose, a length of the activation member protruding beyond the proximal end of the housing increases. ### Claim 9 (depends on 1) The assembly according to claim 1, wherein at least a portion of the dose setting member has a non-circular cross section. ### Claim 10 (depends on 1) The assembly according to claim 1, wherein the activation face of the activation member is curved. ### Claim 11 (depends on 1) The assembly according to claim 1, wherein the activation member is rotationally locked with respect to the dose setting member. ### Claim 12 (depends on 1) The assembly according to claim 1, wherein an axial movement of the activation member during setting of a dose is proportional to a number of units indicated by an indication mechanism of the assembly. ### Claim 13 (depends on 1) The assembly according to claim 1, wherein the activation member is coupled to the piston rod of the assembly via a drive member of the assembly. ### Claim 14 A drug delivery device comprising: a dose setting member configured to be moved by a user from an initial position to a dose set position to set a dose, a main housing part connected to the dose setting member to form a housing of the drug delivery device, the housing having a proximal end and a distal end, an activation member which is coupled to the dose setting member to convert a rotation of the dose setting member with respect to the housing into a proximal movement of the activation member with respect to the dose setting member when the dose setting member is moved from the initial position to the dose set position, the activation member having a proximal end section extending from an activation face of the activation member, the activation face being configured for an interaction with the user, and a drive mechanism disposed within the housing and configured to expel a drug from the drug delivery device when activated, wherein the drug delivery device is configured such that, in the initial position of the dose setting member, the proximal end section is fully received in the housing or slightly protrudes by a protruding distance beyond the proximal end of the housing, wherein the activation member is coupled to a piston rod of the drive mechanism such that the activation member is moved proximally with respect to the dose setting member when the dose setting member is moved from the initial position to the dose set position, and wherein the drug delivery device is further configured such that, when the set dose is increased, an axial extension of the drug delivery device also increases in proportion as the activation member moves proximally with respect to the dose setting member. ### Claim 15 (depends on 14) The drug delivery device according to claim 14, wherein the piston rod is a symmetrical piston rod. ### Claim 16 (depends on 14) The drug delivery device according to claim 14, wherein the protruding distance is less than a length of the dose setting member. ### Claim 17 (depends on 14) The drug delivery device according to claim 14, wherein the protruding distance is less than or equal to 20% of a maximum distance by which the activation member can be moved proximally with respect to the dose setting member during a dose setting operation. ### Claim 18 (depends on 14) The drug delivery device according to claim 14, wherein the protruding distance is zero. ### Claim 19 (depends on 14) The drug delivery device according to claim 14, wherein the activation member is rotationally locked with respect to the dose setting member. ### Claim 20 (depends on 14) The drug delivery device according to claim 14, wherein an axial movement of the activation member during setting of a dose is proportional to a number of units indicated by an indication mechanism of the drug delivery device. ### Claim 21 (depends on 14) The drug delivery device according to claim 14, wherein the activation member is coupled to the piston rod of the drive mechanism via a drive member of the drive mechanism.